Observational studyCardiovascular diabetology2018

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists.

Ghadeer K Dawwas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.